These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2256916)
1. Inhibition of EGF-induced phospholipase C activation in A431 cells by erbstatin, a tyrosine kinase inhibitor. Imoto M; Shimura N; Ui H; Umezawa K Biochem Biophys Res Commun; 1990 Nov; 173(1):208-11. PubMed ID: 2256916 [TBL] [Abstract][Full Text] [Related]
2. Stimulation or inhibition of A431 cell growth by EGF is directly correlated with receptor tyrosine kinase concentration but not with PLC gamma activity. Chen JK; Lin SS Life Sci; 1993; 53(8):635-42. PubMed ID: 8350679 [TBL] [Abstract][Full Text] [Related]
3. Involvement of tyrosine kinase in growth factor-induced phospholipase C activation in NIH3T3 cells. Imoto M; Sujikai I; Ui H; Umezawa K Biochim Biophys Acta; 1993 Feb; 1166(2-3):188-92. PubMed ID: 8443236 [TBL] [Abstract][Full Text] [Related]
4. Stimulation by epidermal growth factor of inositol phosphate production in plasma membranes from A431 cells. Payrastre B; Plantavid M; Chap H Biochim Biophys Acta; 1991 Jan; 1056(1):19-26. PubMed ID: 1984783 [TBL] [Abstract][Full Text] [Related]
5. Effects of substitution of threonine 654 of the epidermal growth factor receptor on epidermal growth factor-mediated activation of phospholipase C. Decker SJ; Ellis C; Pawson T; Velu T J Biol Chem; 1990 Apr; 265(12):7009-15. PubMed ID: 2108964 [TBL] [Abstract][Full Text] [Related]
6. In situ inhibition of tyrosine protein kinase by erbstatin. Imoto M; Umezawa K; Sawa T; Takeuchi T; Umezawa H Biochem Int; 1987 Nov; 15(5):989-95. PubMed ID: 3501720 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of CDP-DG: inositol transferase by inostamycin. Imoto M; Taniguchi Y; Umezawa K J Biochem; 1992 Aug; 112(2):299-302. PubMed ID: 1328172 [TBL] [Abstract][Full Text] [Related]
8. Effects of tyrosine kinase inhibitor, erbstatin, on cell growth and growth-factor/receptor gene expression in human gastric carcinoma cells. Takekura N; Yasui W; Kyo E; Yoshida K; Kameda T; Kitadai Y; Abe K; Umezawa K; Tahara E Int J Cancer; 1991 Apr; 47(6):938-42. PubMed ID: 1849125 [TBL] [Abstract][Full Text] [Related]
9. Antiphosphotyrosine recovery of phospholipase C activity after EGF treatment of A-431 cells. Wahl MI; Daniel TO; Carpenter G Science; 1988 Aug; 241(4868):968-70. PubMed ID: 2457254 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor activates phospholipase C in rat hepatocytes via a different mechanism from that in A431 or rat1hER cells. Liang M; Garrison JC Mol Pharmacol; 1992 Nov; 42(5):743-52. PubMed ID: 1435749 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of EGF-induced cytoskeletal change in A431 cells by inhibitors of phosphatidylinositol turnover. Johtoh N; Umezawa K Drugs Exp Clin Res; 1992; 18(1):1-7. PubMed ID: 1600863 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium. Wahl MI; Nishibe S; Suh PG; Rhee SG; Carpenter G Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1568-72. PubMed ID: 2466293 [TBL] [Abstract][Full Text] [Related]
14. Stimulation of phospholipase C-gamma 1 membrane association by epidermal growth factor. Todderud G; Wahl MI; Rhee SG; Carpenter G Science; 1990 Jul; 249(4966):296-8. PubMed ID: 2374928 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of epidermal growth factor-induced DNA synthesis by tyrosine kinase inhibitors. Umezawa K; Hori T; Tajima H; Imoto M; Isshiki K; Takeuchi T FEBS Lett; 1990 Jan; 260(2):198-200. PubMed ID: 2298299 [TBL] [Abstract][Full Text] [Related]
16. Regulation by ceramide of epidermal growth factor signal transduction and mitogenesis in cell lines overexpressing the growth factor receptor. Gallardo G; Tabraue C; Quintana J; López-Blanco F; Cabrera J; Díaz R; Estévez F; Ruiz de Galarreta CM; Fanjul LF; Santana P Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1305-12. PubMed ID: 11075960 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of protein kinase C by the tyrosine kinase inhibitor erbstatin. Bishop WR; Petrin J; Wang L; Ramesh U; Doll RJ Biochem Pharmacol; 1990 Nov; 40(9):2129-35. PubMed ID: 2242040 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of CDP-DG:inositol transferase activity in src- and erbB2-transformed cells. Imoto M; Taniguchi Y; Fujiwara H; Umezawa K Exp Cell Res; 1994 May; 212(1):151-4. PubMed ID: 7909754 [TBL] [Abstract][Full Text] [Related]
19. Role of guanine nucleotide-binding protein and tyrosine kinase in platelet-activating factor activation of phospholipase C in A431 cells: proposal for dual mechanisms. Thurston AW; Rhee SG; Shukla SD J Pharmacol Exp Ther; 1993 Aug; 266(2):1106-12. PubMed ID: 7689100 [TBL] [Abstract][Full Text] [Related]
20. Differential induction of phosphatidylcholine hydrolysis, diacylglycerol formation and protein kinase C activation by epidermal growth factor and transforming growth factor-alpha in normal human skin fibroblasts and keratinocytes. Reynolds NJ; Talwar HS; Baldassare JJ; Henderson PA; Elder JT; Voorhees JJ; Fisher GJ Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):535-44. PubMed ID: 7690546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]